A Randomized Controlled Clinical Study for Validating the Effectiveness of a Mobile Health Management Program Aimed at Colorectal Cancer Survivors With Comorbid Chronic Conditions
A Randomized Controlled Clinical Study for Validating the Effectiveness of a Mobile Health Management Program Aimed at Colorectal Cancer Survivors With Comorbid Chronic Conditions
The goal of this clinical trial is to evaluate if a mobile health management program can improve chronic disease management among colorectal cancer survivors with comorbid conditions such as hypertension, diabetes, and dyslipidemia. The main questions it aims to answer are:
Does the mobile health application improve clinical outcomes such as blood pressure, blood glucose levels, and lipid profiles? Does the application enhance participants' health behaviors and self-management capabilities? Researchers will compare the mobile health application group to the educational booklet group to see if the digital intervention leads to better health outcomes and adherence to lifestyle changes
Inclusion Criteria:
Specific registration criteria:
Diabetes: Fasting blood sugar (FBS) ≥ 126 mg/dL or HbA1c ≥ 6.5% Dyslipidemia: Low-density lipoprotein cholesterol (LDL) ≥ 130 mg/dL Hypertension: Systolic blood pressure (SBP) ≥ 140 mmHg or Diastolic blood pressure (DBP) ≥ 90 mmHg Individuals who understand the purpose of this study and provide informed consent to participate Individuals who own and use a smartphone (able to use an ICT-based health management program)
Exclusion Criteria: